Bete, Shaton .
HRN: 22-59-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2023
CEFUROXIME 1.5GM (VIAL)
02/17/2023
02/17/2023
IV
1.5 G
Loading Dose
Post Coital Bleeding, For Pre OR Vaginal Expolartion And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes